Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium

Estimating Direct Effects in Cohort and Case–Control Studies

(2010) Stijn Vansteelandt   EPIDEMIOLOGY

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

(2010) C. Ford et al.   Multiple Sclerosis Journal

Rapid disease course in African Americans with multiple sclerosis

(2010) I. Kister et al.   NEUROLOGY

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

(2009) M. Trojano et al.   ANNALS OF NEUROLOGY

Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients

(2009) M Debouverie et al.   Multiple Sclerosis Journal

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation

(2009) PJ Veugelers et al.   Multiple Sclerosis Journal

Will Rogers phenomenon in multiple sclerosis

(2008) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

The role of cancer registries in cancer control

(2008) Donald Maxwell Parkin   International Journal of Clinical Oncology